![Christopher Kiritsy](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Christopher Kiritsy
Fondateur chez
Precision Kapital LLC
Fortune : 38 205 $ au 30/06/2026
Profil
Christopher P.
Kiritsy is the founder of Arisaph Pharmaceuticals, Inc., founded in 1999, where the titles held included President, Chief Executive Officer & Director from 2005 to 2018.
Mr. Kiritsy is the founder of Precision Kapital LLC, founded in 2018, holding the title of Member since 2018.
Mr. Kiritsy currently serves as an Independent Director at Palvella Therapeutics, Inc. starting in 2024.
Former positions include Chairman at Avaxia Biologics, Inc., Associate Director-Product Development at the University of Oregon, Director at Melinta Subsidiary Corp., Director at HTG Molecular Diagnostics, Inc., Independent Director at Pieris Pharmaceuticals, Inc. from 2016 to 2024, and CFO & Executive VP-Corporate Development at KOS Pharmaceuticals, Inc. Education includes an MBA from Boston University and an undergraduate degree from Bowdoin College.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
0% | 10/06/2026 | 250 ( 0% ) | 38 205 $ | 30/06/2026 |
Postes actifs de Christopher Kiritsy
| Sociétés | Poste | Début |
|---|---|---|
Precision Kapital LLC | Fondateur | 01/01/2018 |
Anciens postes connus de Christopher Kiritsy
| Sociétés | Poste | Fin |
|---|---|---|
| PIERIS PHARMACEUTICALS | Directeur/Membre du Conseil | 13/12/2024 |
Arisaph Pharmaceuticals, Inc.
 Arisaph Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Provides drug discovery services | Fondateur | 01/01/2018 |
KOS Pharmaceuticals, Inc.
 KOS Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Directeur Financier/CFO | 23/05/2005 |
| HTG MOLECULAR DIAGNOSTICS, INC. | Directeur/Membre du Conseil | - |
Melinta Subsidiary Corp.
 Melinta Subsidiary Corp. Pharmaceuticals: MajorHealth Technology Develops and markets pharmaceutical products for the treatment of life-threatening infections | Directeur/Membre du Conseil | - |
Formation de Christopher Kiritsy
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
37
Relations au 1er degré
10
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 10 |
|---|---|
KOS Pharmaceuticals, Inc.
KOS Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
HTG Molecular Diagnostics, Inc.
 HTG Molecular Diagnostics, Inc. Miscellaneous Commercial ServicesCommercial Services Provides molecular technology solutions | Commercial Services |
Arisaph Pharmaceuticals, Inc.
Arisaph Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Provides drug discovery services | Health Technology |
Avaxia Biologics, Inc.
 Avaxia Biologics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company | Health Technology |
Boston University
 Boston University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bowdoin College
 Bowdoin College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Oregon
 University of Oregon Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Melinta Subsidiary Corp.
Melinta Subsidiary Corp. Pharmaceuticals: MajorHealth Technology Develops and markets pharmaceutical products for the treatment of life-threatening infections | Health Technology |
Pieris Pharmaceuticals, Inc.
 Pieris Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops and markets an anticalin-brand protein technology | Health Technology |
Precision Kapital LLC |
Choisissez Zonebourse 
